Video

Patient-to-Patient: What to Expect in a Clinical Trial

Janet Freeman-Daily, patient advocate and CURE contributor, discusses some key points that patients should know about enrolling in clinical trials.

Janet Freeman-Daily, patient advocate and CURE contributor, discusses some key points that patients should know about enrolling in clinical trials.

Freeman-Daily says that clinical trials are especially important for patients like her who have metastatic lung cancer, for which there is currently no cure but a number of options and clinical trials that may benefit patients.

Before joining a clinical trial, patients should know their risk and understand the difference between each of the three phases of clinical trials. Also, patients should never think that they may not be treated in a clinical trial. Even if randomized to placebo, they will always get the best standard of care.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.
Image of woman with brown hair.
Image of man with black hair.
Image of bald man.
Image of man.
Image of Kumar.
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.